Dallas, TX (PRWEB) August 13, 2014
The North Texas Chapter of the Association of Clinical Research Professionals and Baylor Research Institute have joined forces with Myriad Genetics, Inc., Lynch Syndrome International, Progeny and Ambry Genetics to present a comprehensive awareness session on Lynch syndrome (a subset of HNPCC) which creates a strong predisposition to hereditary cancers as a result of a mismatch repair gene in which individuals, often at a younger than usual age, a high risk of developing colorectal, endometrial, ovarian and other various aggressive cancers including cancer of the bile duct, the brain, the breast, the gallbladder, the gastrointestinal tract, the hepatobiliary tract, the kidney, the pancreas, the prostate, the skin, the small bowel, the stomach, the thyroid and the ureter.
During this free community outreach presentation, Dr. Patrick M. Lynch, JD, MD, Professor of Medicine at the University of Texas, MD Anderson Cancer Center, Houston, Texas will be explaining the key clinical features of Lynch syndrome, how to determine the appropriate circumstances when genetic testing is appropriate, how to conduct tumor testing, how to follow clinical procedures for diagnosis and for management cancer screenings for those affected by Lynch syndrome.
This excellent program offers an opportunity for physicians, nurses, nursing assistants, students, and persons who are at risk for hereditary cancers to learn more about Lynch syndrome and learn how to protect themselves and others, from one of the finest world experts.
There is no cost for this session. To reserve your complimentary spot, or inquire about CE contact hour costs, please contact cazghani(at)gmail(dot)com or text 903-253-4468.
An additional nominal charge applies for for Contact CE Units.
When:
Saturday, August 16, 2014, 8:30 a.m. to 11:00 a.m.
Where:
The Fordtran Room – Lieberman Building
3434 Live Oak Street, Dallas, TX 75204
Free Parking Provided
About Lynch Syndrome:
Lynch syndrome runs in families. It is a severely underdiagnosed hereditary cancer condition which affects one of every 440 persons. In the United States alone, 800,000 to 1,000,000 persons are thought to be affected, yet less than ten percent are currently diagnosed. As a result, often many family members can contract cancer.
Creating a high predisposition to colorectal cancer, endometrial cancer, bladder tract cancers, ovarian cancer and a litany of other cancers, it often occurs at a younger than average age.
Today, there is hope for these families. Knowing one's family history of cancer and consulting a knowledgeable medical provider, once diagnosed through genetic testing, individuals qualify for annual comprehensive cancer screenings which may detect growths, polyps, and tumors, and remove or treat them before they become life threatening.